NCT02523820View on ClinicalTrials.gov

Nebulized Corticosteroid for Post Extubation Stridor in Children

PHASE3CompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

May 30, 2016

Study Completion Date

August 30, 2016

Conditions
Stridor
Interventions
DRUG

fluticasone propionate

Flixotide 1 mg + NSS upto 4 ml nebulized after extubation. Record vital signs and modified Westley score at 0, 15, 30, 60 min and 2,4,6 hours

DRUG

Placebo

NSS 4 ml nebulized after extubation. Record vital signs and modified Westley score at 0, 15, 30, 60 min and 2,4,6 hours

Trial Locations (1)

10400

Department of Pediatric,Ramathibodi Hospital, Bangkok

All Listed Sponsors
lead

Ramathibodi Hospital

OTHER

NCT02523820 - Nebulized Corticosteroid for Post Extubation Stridor in Children | Biotech Hunter | Biotech Hunter